Architect Tacrolimus: Model 1L77
FDA 510(k) K070820 · Fujirebio Diagnostics,Inc.
510(k) numberK070820
Submission
- Device name
- Architect Tacrolimus: Model 1L77
- Applicant
- Fujirebio Diagnostics,Inc.
Malvern, PA, US - Received
- March 26, 2007
- Decision date
- August 1, 2007
- Decision
- Substantially Equivalent (SESE)
- Type
- Traditional 510(k)
- Summary
- 510(k) summary available from FDA
Device classification
- Product code
- MLM – Enzyme Immunoassay, Tracrolimus
- Device class
- Class II (moderate risk)
- Regulation
- 21 CFR 862.1678
- Specialty
- Clinical Chemistry
Other 510(k)s with product code MLM
| 510(k) | Device | Applicant | Decision |
|---|---|---|---|
| K203833 | Tacrolimus Assay KitMLM · Traditional | Shanghai Genext Medical Technology Co., Ltd. | 01/27/2023SE |
| K173857 | Elecsys TacrolimusMLM · Traditional | Roche Diagnostics | 11/06/2018SE |
| K150168 | Dimension Tacrolimus Flex® Reagent Cartridge (TAC), Dimension Tacrolimus Calibrator (TAC…MLM · Traditional | Siemens Healthcare Diagnostics | 11/04/2015SE |
| K123343 | Thermo Scientific QMS Tacrolimus Assay and CalibratorsMLM · Traditional | Microgenics Corp. | 07/11/2013SE |
| K063868 | Masstrak Immunosuppressants KitMLM · Traditional | Waters Corporation | 05/25/2007SE |
| K060502 | Dimension Tacr Flex Reagent Cartridge, Model DF107MLM · Traditional | Dade Behring, Inc. | 05/18/2006SE |
| K060385 | Emit 2000 Tacrolimus Assay and Sample Pretreatment ReagentMLM · Traditional | Dade Behring, Inc. | 04/06/2006SE |
| K050206 | Cedia Tacrolimus AssayMLM · Traditional | Microgenics Corp. | 03/15/2005SE |
More from Microgenics Corp.
| 510(k) | Device | Decision |
|---|---|---|
| K250925 | ADVIA Centaur Cytokeratin Fragment 21-1OVK · Traditional | 12/16/2025SE |
| K242706 | Lumipulse G pTau217/ß-Amyloid 1-42 Plasma RatioSET · Traditional | 05/16/2025SE |
| K192524 | Lumipulse G CA15-3MOI · Traditional | 09/04/2020SE |
| K192380 | ST Aia-Pack BNPNBC · Traditional | 08/24/2020SE |
| K200997 | Lumipulse G CA19-9-NNIG · Special | 05/14/2020SE |
| K190702 | Lumipulse G whole PTHCEW · Traditional | 08/30/2019SE |
| K172713 | Lumipulse G BRAHMS PCT Immunoreaction Cartridges, Lumipulse G BRAHMS PCT…PRI · Traditional | 12/10/2017SE |
| K171103 | Lumipulse G TSH-III Immunoreaction CartridgesJLW · Traditional | 07/28/2017SE |
| K163546 | Lumipulse G Progesterone-N CalibratorsJIT · Abbreviated | 01/13/2017SE |
| K163534 | Lumipulse G FSH-N CalibratorsJIT · Abbreviated | 01/13/2017SE |
Questions and answers
When was Architect Tacrolimus: Model 1L77 cleared by the FDA?
Architect Tacrolimus: Model 1L77 (K070820) received a 510(k) decision of Substantially Equivalent on August 1, 2007, 128 days after the submission was received.
What is the product code of K070820?
The FDA product code is MLM – Enzyme Immunoassay, Tracrolimus, a Class II (moderate risk) device regulated under 21 CFR 862.1678.